Bénard J, Bourhis J, Riou G
Laboratoire de pharmacologie clinique et moléculaire, institut Gustave-Roussy, Villejuif, France.
Bull Cancer. 1991 Jan;78(1):91-7.
N-myc amplification and ploïdic index are important prognosis factors in neuroblastoma. Combined overexpression of the multidrug resistance gene, MDR1 and of Glutathion-S-Transferase, GST-pi may be related to the response of tumors to chemotherapy. Measurements of these parameters may contribute to define responders and non-responders to chemotherapy and provide the clinician with additional criteria to manage treatment.
N-myc扩增和倍体指数是神经母细胞瘤重要的预后因素。多药耐药基因MDR1和谷胱甘肽S-转移酶GST-pi的联合过表达可能与肿瘤对化疗的反应有关。对这些参数的测量可能有助于确定化疗的反应者和无反应者,并为临床医生提供管理治疗的额外标准。